Top Pharma News of the Week – May 7th

All The Most Important Pharmaceutical News Stories Of The Week – May 2018 – Week #2 Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma

May 1, 2018

Novartis has announced that the US Food and Drug Administration (FDA) has approved Kymriah® (tisagenlecleucel) suspension for intravenous…